ACTIVExtend: 24 months of alendronate after 18 months of abaloparatide or placebo for postmenopausal osteoporosis
Journal of Clinical Endocrinology & Metabolism | Aug 12, 2018
Reproductive hormones and subclinical cardiovascular disease in midlife women
Journal of Clinical Endocrinology & Metabolism | Aug 11, 2018